Drug Shortage Report for EMLA CREAM
| Report ID | 209402 |
| Drug Identification Number | 00886858 |
| Brand name | EMLA CREAM |
| Common or Proper name | lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LIDOCAINE PRILOCAINE |
| Strength(s) | 2.5% 2.5% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 1 Tube |
| ATC code | D04AB |
| ATC description | ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-12-15 |
| Actual start date | 2023-12-20 |
| Estimated end date | 2024-01-15 |
| Actual end date | 2024-01-08 |
| Shortage status | Resolved |
| Updated date | 2024-01-18 |
| Company comments | VR44798CA1 / CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2024-01-18 | French | Compare |
| v15 | 2024-01-18 | English | Compare |
| v14 | 2024-01-04 | French | Compare |
| v13 | 2024-01-04 | English | Compare |
| v12 | 2023-12-21 | English | Compare |
| v11 | 2023-12-19 | French | Compare |
| v10 | 2023-12-19 | English | Compare |
| v9 | 2023-12-16 | English | Compare |
| v8 | 2023-12-12 | French | Compare |
| v7 | 2023-12-12 | English | Compare |
| v6 | 2023-12-12 | English | Compare |
| v5 | 2023-12-02 | English | Compare |
| v4 | 2023-12-01 | French | Compare |
| v3 | 2023-12-01 | English | Compare |
| v2 | 2023-11-06 | French | Compare |
| v1 | 2023-11-06 | English | Compare |
Showing 1 to 16 of 16